- Black boxes indicate covariates whose 95% credibility interval excluded 1 (or 0 in the case of Average Dose).▼indicates a negative association with the outcome variable in question and the covariate,▲indicates a positive association. X’d out cells indicate that the covariate in question was not included in the model
- amale gender (n = 97/128) vs not male (female = 30/128 + non-binary = 1/128) with male = 0 and non-male = 1
- bplacebo (n = 67) vs nabiximols (n = 61) with the placebo group = 0 and nabiximols = 1
- cHigher SF-36 scores indicate better outcome, in this case less pain. This can be confusing, therefore, to save confusion we have reversed the direction of the SF-36 so that the arrow represents the change in odds of reducing cannabis use associated with higher pain at baseline. So, more pain at baseline was associated with greater odds of reducing cannabis and greater average dose of medication
Substance Abuse Treatment, Prevention, and Policy